Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs, TriLink Bio Ink Supply Agreement

NEW YORK (GenomeWeb) — New England Biolabs will supply RNA synthesis reagents to TriLink Biotechnologies under an agreement announced by the companies today.

Specific terms of the agreement call for Ipswich, Mass.-based NEB to manufacture and supply enzymes for San Diego-based TriLink for in vitro transcription, capping, and poly(A) tailing of RNA.

"NEB is a leading supplier of molecular biology enzymes and associated reagents for life science research," TriLink President and CEO Richard Hogrefe said in a statement. "This agreement aligns NEB and TriLink in providing the market with the highest quality RNA for projects of all scales."

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.